# A Study of LY2140023 in Healthy Males and Females

> **NCT01591330** · PHASE1 · COMPLETED · sponsor: **Denovo Biopharma LLC** · enrollment: 35 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** LY2140023 Reference form
- **DRUG:** LY2140023 Test-Low
- **DRUG:** LY2140023 Test-Medium
- **DRUG:** LY2140023 Test-High

## Key facts

- **NCT ID:** NCT01591330
- **Lead sponsor:** Denovo Biopharma LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2012-06
- **Final completion:** 2012-08
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2021-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01591330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01591330, "A Study of LY2140023 in Healthy Males and Females". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01591330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*